Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer

Maria Rusan; Simone Weiss; Karina Dalsgaard Sørensen

doi:10.21037/tau-23-589

Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer

Transl Androl Urol. 2024 Apr 30;13(4):626-630. doi: 10.21037/tau-23-589. Epub 2024 Apr 18.

Authors

Maria Rusan^#^{1

2

3}, Simone Weiss^#^{1

3}, Karina Dalsgaard Sørensen^{1

3}

Affiliations

¹ Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
² Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
³ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

^# Contributed equally.

No abstract available

Keywords: PGAM2; Prostate cancer; clustered regularly interspaced short palindromic repeats screening (CRISPR screening); enzalutamide resistance; metabolic enzymes.

Publication types

Editorial
Comment